BSX Investors: Did Boston Scientific Fraud Cost You? Deadline Nears for Securities Lawsuit Claim.

LOS ANGELES, March 16, 2026 – Glancy Prongay Wolke & Rotter LLP has issued a reminder to investors regarding an upcoming deadline for a class action lawsuit. Individuals who purchased or otherwise acquired Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX) securities between July 23, 2025, and February 3, 2026, inclusive, are affected. The deadline for investors to file a motion to be appointed as lead plaintiff in this class action is May 4, 2026.

Boston Scientific Corporation (BSX) currently holds an RS Score of 51.96, placing it in the 10.20th percentile within its country and the 7.14th percentile in its sector. The stock demonstrates strong performance in Profitability, scoring 80.40. However, areas such as Valuation (46.92), Growth (14.10), Momentum (8.38), and EPS Revisions (70.00) appear weaker. Want to discover which stocks rank the highest? Start your free 7-day trial at rankedstocks.com.